Targeted Axillary Dissection (TAD) in Early-stage Node Positive Breast Cancer

Clinical trial NCT04671511 · RECRUITING

Trial details

NCT number: NCT04671511
Sponsor: Jewish General Hospital
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Breast Cancer Female Early-stage Breast Cancer Lymph Node Metastases Axillary Metastases Sentinel Lymph Node

Start date: 2021-03-30
Primary completion: 2026-07-01
Enrollment: 98

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.